semaglutide aha GLP-1 Drugs Lower Risk of Death by 44% in Obesity and Autoimmune Disease SELECT Trial

Its a moment that requires a shift in strategy, a transition from the initial "honeymoon phase" of the medication to a more nuanced, metabolic-focused approach

Review handling: Note refrigerated storage and cold-chain needs when applicable

Although clinically significant hypotension is uncommon, gradual improvements may require adjustments to existing blood pressure regimens

In clinical trials, participants saw an average weight loss of approximately 15% over 68 weeks, which considerably outperformed placebo results

However, PlexusDx begins all patients at medically appropriate starting levels based on medical history and safety guidelines